Published Aug 15, 2026
Biodexa's Pipeline Reset: A 1-for-10,000 Reverse Split, a $1.5M Market Cap, and a Real Phase 3 Readout in Q3 2026
In-depth research on BDRX covering the business overview, key financial moves, risk frame, and the bottom-line on what changed since the last report.
5,503 words24 min read
Read report